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t is the sprin the the year 2000. and you are looking forward to your first sum
mer of the new Millennium. Baseball season has started, the National Basket bal
Asociation playoff' are on the horizon, and Wimbledon the French Open, and the
U.S. Open are all ahead of you. And, best of all, this is an Olympic year. During the
f[all, your television will be taken over by gymnastics, soccer, sofibaIl, and track &
field with interesting vignettes telling the amazing stories of sacrifice and hardship
leading up to Olympic glory. You even remember, with misty-eyed nostalgia, your
days as a high school athlete: it is not important that it was in the sphere of intra
murals. YOU WERE A CONTENDER! If you bad applied yourself, you too could have
been an Olympian. Now, you are a hard-working attorney looking forward to a sum-
mer of sitting on your couch and watching other great athletes. Little did you know
that you would play a part in the 2000 Olympic Games in Sydney Australia.
A Practitioner's Guide To Understanding
By Jill Pilgrim and Kim Betz
Isn't life funny?
A few months prior to the start of the 2000 US.
Olympic Team Trials for track & field, Amanda, a top
U0S. athlete, comes to your office seeking guidance. Like
other athletes, she has been drug tested consistently
throughout her career. She admits, however, that the
recent media attention given to the creation of new
organizations involved with drug testing,l the new meth-
ods of drug testing, and the rise in the number of athletes
that have recently tested positive are all somewhat dis-
concerting to her, especially since this is an Olympic year.
Amanda is confident that she will make the Olympic
team and compete in the U.S., Canada, and Australia
before reporting to the Olympic Village in September of
2000. While she has professed to be drug free, she would
like to better understand the changes that have been
made in the recent months with respect to Olympic drug
testing. Amanda has provided you with her training
schedule to assist you in your legal analysis. (See
Amanda's Training Schedule, infra, p. 212.)
they fully understand the jurisdictional issues that arise
with respect to every sample taken, until they are caught
in a crisis. This Article attempts to untangle the web of
rules and regulations and provide athletes, coaches, and
athlete representatives with a working knowledge of: 1)
when an athlete is subject to drug testing, 2) which
organizations oversee doping control, and 3) the potential
problems that arise when m-ore than one organization
is involved.
Brief History of Cheating
Ever since the ancient Olympic Games, athletes have
sought the glory of being crowned Olympic champions -
with all the attendant accolades, gifts, and awards. Over
time. this quest for greatness has tempted athletes to
obtain athletic prowess by dishonest means. Drug test-
ing of athletes, to stamp out performance-enhancing
drug use, began within the Olympic Movement: in 1968.
It continues today.
Where do you begin your research in order to provide In modern times, unscrupulous doctors have assisted
adequate advice to Amanda? athletes in gaining an edge against opponents. The most
notorious and recent Olympic exposure of cheating
hile many top U.S. Olympic-caliber athletes have occurred during the 1988 Olympic Games in Seoul.
been drug tested throughout their careers. few truly Korea. where Ben Johnson was exposed as a steroid user.
understand the drug testing process. The ever-changing However, not all Olympic drug infractions are the prod-
rules and regulations, as well as the increase in the uct of intentional actions on the part of athletes.
number of doping control programs 2 have proven to be Recently several former East German athletes brought
confu*sing and sometimes inconsistent, despite appearing suit in Germany alleging that they were unknowingly
. . ... ... .given performance-enhancing
-rugTestig Within the OCympic Movement drugs, under the guise of,"vita-
mains." These cases reinforce to
to assist in the fight against doping n sport. Many the public what Olympic athletes have known for decades
organizations cannot interpret their own rules, nor do drugs do exist in sports.
When is an Athlete Subject to
Drug Testing?
To begin your research and advise Amanda, you will
need to obtain the following documents:
* International Olympic Committee Charter
4
* International Olympic Committee Medical Code
5
* International Amateur Athletic Federation Rules
6
* International Amateur Athletic Federation Procedural
Guidelines for Doping Control
7
* Ted Stevens Olympic & Amateur Sports Act 8
* United States Olympic Committee National Anti-
Doping Program Document 9
* United States Olympic Committee Memorandum of
Agreement with USA Track & Field 10




* United States Olympic Committee Code of Conduct -
2000 Olympic Games
1 3
* United States Olympic Committee Grievance
Procedures for Code of Conduct and Team
Selection - 2000 Olympic Games
14
* United States Olympic Committee Bilateral
Agreement with the Australian Drug Testing
Agency
15
* United States Olympic Committee Bilateral
Agreement with the Canadian Centre for Ethics
in Sports
16
* USA Track & Field 17 Governance Handbook
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Now that you have all the materials you need, you can
begin your legal analysis. Amanda tells you that she
does not understand why she gets tested during some
competitions and not others, and more importantly, she
tells you she does not understand why she is tested at home.
Based upon your exhaustive review of the relevant
documents, you now understand that there are two types
of drug testing that Olympic-caliber athletes are subject
to - "in-competition" and "out-of-competition." Slightly
different rules apply to each category of testing.19
In-competition drug testing occurs during a specified
competition. Athletes are notified that they will be tested
upon completion of an event, during a competition. Once
notified, athletes are required to provide a urine sample
while at the competition site. The procedure by which an
athlete is selected for drug testing depends upon the
organization that is responsible for conducting drug test-
ing at each particular event. The selection process of
USA Track & Field (USATF) is random, based upon
place-finish.
Out-of-competition drug testing, on the other hand,
occurs outside of competition. Usually, out-of-competition
drug tests are conducted with no advance notice to the
athlete and may occur at any time (i.e. home, work, or
training facility).20 Once notified, athletes are required
to submit to the drug test, regardless of where they may
be located at the time of notification. 2 1 The process by
which an athlete is selected for out-of-competition drug
testing is also organization-specific. For example,
USATF randomly
selects a specified num-
> ber of athletes for test-
ing each month. USATF
selects athletes based
upon their ranking in a





t, 2000)Now that Amanda
i15Septern r 14 , 2000) understands the types of
2drug tests to which she
5is subject, it is critical
Necessary Tools
that she understands what organizations have the
authority22 to carry out the drug testing process.
Almost every sports organization today conducts or
participates in some type of drug testing program,
regardless of whether its athletes are amateur or profes-
sional. Professional sports organizations such as the
National Basketball Association, Women's National
Basketball Association, National Football League, Major
League Baseball, and National Hockey League all con-
duct their own drug testing programs, have their own
drug testing protocols, and coordinate their own lists of
prohibited substances. An athlete competing in one of
these professional leagues is subject only to its drug test-
ing program.
Unlike athletes associated with professional organiza-
tions, elite Olympic athletes are subject to drug testing
by multiple organizations. Within the Olympic
Movement, the International Olympic Committee (IOC),
some International Federations (IFs), the United States
Olympic Committee (USOC), and certain other national
organizations, by agreement, all conduct drug testing
programs and have the ability to drug test U.S. athletes
either during competition, out-of-competition, or both.
However, the likelihood that an athlete will be subject to
drug testing by all four organizations is heavily depend-
ent on the level at which the athlete competes.
2 3
In the United States
Athletes who compete on a national level can expect to
be drug tested by the USOC. 2 4 The USOC, through its
National Anti-Doping Program (NADP), is responsible
for coordinating both in-competition and out-of-competi-
tion drug testing for each National Governing Body
(NGB).2 5 The NADP is implemented through individual
memoranda of agreement (MOA) between the USOC and
each individual NGB. Each MOA establishes the terms
and conditions by which the USOC is responsible for con-
ducting drug testing for an NGB.
Under the USOC/USATF MOA, USATF is responsible
for selecting certain domestic competitions in which drug
testing will occur, for determining the process by which
athletes are selected for domestic out-of-competition drug
testing, and for implementing the disciplinary process
upon notice that a sample has tested positive for a pro-
hibited substance. 26 The USOC, on the other hand, is
responsible for coordinating every other aspect of the
drug testing process. Thus, in the event that Amanda
participates in a domestic competition that has been
selected for drug testing by USATF, she can expect drug
testing to take place by the USOC, in accordance with the
NADP, as amended by the MOA. Furthermore, as the
USOC is also responsible for conducting out-of-competi-
tion drug testing pursuant to the NADP and MOA, in the
event that Amanda ranks among the top athletes in her
event, she will be drug tested outside of competition as well.
2 7
Internationally
Athletes competing on an international level, either
domestically or abroad, also can expect to be drug tested
by their respective international federation. The interna-
tional federation for track & field,2 8 the International
Amateur Athletic Federation (IAAF), is responsible for
coordinating all aspects of track & field on an interna-
tional level, including the implementation of a drug test-
ing program. 29 According to the rules associated with the
IAAF's drug testing program, the IAAF is responsible for
conducting drug testing during World Championships
and World Cups, Grand Prix and Permit Meetings, and
other designated competitions. 30 In addition, IAAF rules
authorize it to conduct out-of-competition drug testing on
a member federation's athletes.
31
Thus, when Amanda competes abroad or in certain
internationally-sanctioned competitions in the U.S.,
32
the IAAF will have the authority to drug test Amanda
during that competition. Furthermore, since Amanda is
a world-ranked athlete, she is eligible to be drug tested
outside of competition by the IAAF. Similar to the out-of-
competition drug test conducted by the USOC, an out-of-
competition drug test conducted by the IAAF can occur at
any time and any place, with no notice to the athlete.
Special Testing Arrangements
When Amanda travels to Australia for training and/or
competition prior to the U.S. Olympic Trials, she will be
subject to drug testing by the Australian Sports Drug
Agency (ASDA), as well as the USOC. Pursuant to a
"Trilateral Agreement," the ASDA, the Canadian Centre
for Ethics in Sport (CCES), and the USOC all have
agreed to allow each country's respective National
Olympic Committee (NOC) to drug test the other coun-
try's athletes. This Trilateral Agreement has been imple-
mented through individual bilateral agreements, which
set forth the terms and conditions by which the drug
tests must be conducted.
According to the bilateral agreement between the
USOC and the ASDA, 33 the ASDA has the authority to
drug test an American athlete while he or she is residing,
training, and/or competing in Australia. 3 4 Similarly, the
USOC has the authority to drug test an Australian ath-
lete that is residing, training and/or competing in the
U.S. In addition, pursuant to this agreement, the USOC
also has the ability to drug test U.S. athletes while they
are competing, training, or residing in Australia.
Notwithstanding the ASDA's and the USOC's ability to
drug test a U.S. athlete in Australia, the responsibility of
conducting disciplinary procedures still rests with each
athlete's federation.
35
Finally, in some instances, Olympic athletes may be
subject to drug testing conducted by the recently-created
World Anti-doping Agency (WADA). WADA was created
under the auspices of the International Olympic
Committee, with the goal of coordinating drug testing on
a global level during the intervals between the Pan
American and Olympic Games. However, WADA's limited
objective for the year 2000 is to conduct out-of-competi-
tion drug testing on those athletes whose national feder-
ations, IFs, or respective NOCs do not have drug testing
programs. 36 In addition, WADA will have the responsi-
bility of monitoring the procedure of drug testing by the
Australian Olympic Committee during the 2000 Olympic
Games. Because both the USOC and IAAF have drug
testing programs, the likelihood that an American track
& field athlete will be subject to drug testing by WADA is
minimal.
Drug Testing at Olympic Trials Events
Each NGB has a selection process for determining
which athletes will represent the United States at the
Olympic Games. Some NGBs evaluate performance over
a series of competitions, while other NGBs base selection
on performance at a specific Olympic trials event.
USATF's selection process falls into the latter category.
All athletes participating in the U.S. Olympic Team
Trials for track & field are eligible to be drug tested.
Pursuant to its authority under the NADP, the USOC
has the authority to conduct drug testing at all Olympic
and Pan American trials competitions. 37 Thus, Amanda
should be informed that, if selected to the U.S. Olympic
team, she can expect to be drug tested upon completion of
her event.
Disciplinary Procedures
Each sports organization described above has a disci-
plinary process that is implemented once an athlete's
urine sample reveals the presence of a prohibited sub-
stance. Pursuant to the rules of the USOC's NADP, the
IAAF, and the ASDAIUSOC bilateral agreement, discipli-
nary proceedings are to be held by the appropriate
NGB.38 Thus, once an NGB is notified by one of these
organizations that a urine sample has tested positive for
a prohibited substance, the NGB is responsible for imple-
menting disciplinary proceedings. For USATF, the disci-
plinary process begins with the implementation of
USATF Regulation 10: Doping Control.
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USATF Regulation 10
USATF Regulation 10 is the provision within the
USATF By-Laws that authorizes USATF to implement
disciplinary proceedings against an athlete.
Additionally, it sets forth the disciplinary process that
USATF is required to implement once it has been notified
that a urine sample has tested positive for a prohibited
substance.
Under Regulation 10, athletes are afforded certain
rights and opportunities, which include: (1) the right to
have "B" sample analyzed, 40 (2) the right to a full hear-
ing,4 1 and (3) the right to an appeal. As of January 2000,
the American Arbitration Association (AAA) is responsi-
ble for adjudicating all hearings and appeals for USATF,
pursuant to USATF Regulation 10.42
USOC Article IX
In addition to USATF Regulation 10, an athlete may
utilize another forum designated by Article IX of the
USOC Constitution and Chapter IX of the USOC By-
Laws to resolve issues of eligibility. According to these
provisions, an athlete who believes that he or she has
been denied the opportunity to participate in a protected
competition 4 3 has the opportunity to have an expedited
hearing before the AAA. 4 4 Arbitrations that are held pur-
suant to this article are held in accordance with special
AAA rules and regulations relating to Olympic and Pan
American Games competitions. Athletes who utilize this
provision are entitled to a hearing and a decision within
48 hours of delivery of the notice of the hearing. 4 5
Thus, if one of Amanda's urine samples tests positive
during either an in-competition or out-of-competition
drug test, she would have the opportunity to have the
matter heard by an AAA panel pursuant to USATF
Regulation 10. In the event that USATF denied Amanda
the opportunity to compete, she could utilize the AAA
arbitration in accordance with Article IX of t
Constitution and Chapter IX of the USOC By-I
Olympic Trials:
Nomination to the Olympic Team
According to the USOC Constitution and By-
USOC has exclusive jurisdiction over memb
U.S. Olympic team and all matters relating to
ticipation in the Olympic Games, once the Olyr
has been nominated by an NGB.4 6 Consistent
authority, the USOC has established a set of pi
known as the USOC Grievance Procedures, tha
the appropriate process for handling any di
and/or grievance matters. 4 7 Members of
Olympic team are required to utilize these proc,
any issue that may arise regarding their
and/or participation in the Olympic Games.
Post-Olympic Trials Jurisdictional I:
Immediately upon completion of the U.S. 01
als and an athlete's return to competition/trair
the organizations resume their authority to
However, for all members of the U.S. Olympic
USOC simultaneously retains its authority to I
disciplinary matters and grievance complaint
relate to members of the U.S. Olympic tean
Olympic Games. The USOC retains this auth(
the completion of the 2000
Olympic Games. Thus,
notwithstanding the ability of
any organization to conduct
drug testing on an athlete and
its authority to handle any sub- cordingMovement
sequent disciplinary proceed- on
ings, the USOC Constitution esofsubst•stimular
and By-Laws specify that the narcotic
USOC has authority over any anabogic
issue related to discipline diuretics
and/or grievance complaints. peptideanalogu
As a result, a situation of over- Other sub
lapping jurisdiction is created, cumstancal:cohol
the resolution of which remains cannabi
unclear. local an"glucocor
Consider the following sce- betn blo
nario. Amanda, as indicated in "he posoffense for
her event schedule, competes in :a ban or
SpOrt s c(
Australia after the Olympic trials and is selected for drug
testing. Assume that her sample reveals the presence of
a prohibited substance. ASDA is required to notify the
USOC of the positive finding. The USOC then is
required to notify USATF, pursuant to the USOC/ASDA
Bilateral Agreement. Upon notification, USATF is
required to notify Amanda that her sample has tested
positive for a prohibited substance and inform her that
certain disciplinary procedures will be implemented.
However, it is unclear whether the USOC Grievance
Procedures or USATF Regulation 10 applies.
Because this sample was taken pursuant to the
ASDA's authority, under the USOC/ASDA Bilateral
Agreement, the athlete's home federation is responsible
for handling the disciplinary process. 48  However,
because Amanda is now a member of the U.S. Olympic
team, the USOC also has jurisdiction over the discipli-
nary process. 4 9 Which organization is responsible for
resolving the matter is unclear. 50 This conflict exists not
only with drug testing conducted pursuant to the
USOC/ASDA Bilateral Agreement, but also with drug
tests that are conducted pursuant to the USOC's NADP
and the IAAF's doping control program, each of which details
specific procedures that must follow a positive finding.
Olympic Games: JOC Authority
As the "supreme authority"5 1 within the Olympic
Movement, the IOC is responsible for conducting drug
Wrld Anti-Doping Code an
to Appendix A of the new Olympic
SAnti-Dloping Code.' which took
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ihte sanon for a first time
smost drugs include:
participation m one or several
ompetitions in an y capacity
whatsoever
-a fine of up to U.S. $100,000
•suspension from any competition for a
minimum period of two years
•automatic invabdation of anyv results
obtained during competit ion when doping
was detected. 1
Repeat offenses carry the following sanctions:
-a life ban on participation in any sports
event in any capacity whatsoever
*a fine of up to U.S. $1,000,000
•suspension (between four years and life)
from all sports competition.'
l Olvmpiw Mm 'metnt Anti Doting (Cod', Appcn*dir A
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ing org/cOdn anni ,dopig/AntiDopmtg('md.pdV .
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testing during the Olympic Games, pursuant to the rules
and regulations established by the JOC Medical Code.
The IOC Medical Code also sets forth the disciplinary
process that must be followed once a drug test reveals the
presence of a prohibited substance. 5 2 According to those
procedures, the IOC Medical Commission and the IOC
Executive Committee have the sole authority to decide issues
relating to positive drug tests.5 3 However, all decisions may
be appealed to the Court of Arbitration for Sport (CAS).
54
Thus, if an American athlete competing at the Olympic
Games is drug tested and the sample tests positive, the
Chef de Mission of the U.S. Olympic delegation is notified
that the test has revealed the presence of a prohibited
substance. According to the procedures set forth in the
IOC Medical Code, the IOC Medical Commission deter-
mines whether a doping violation has taken place and
refers its decision to the IOC Executive Committee for
approval and the imposition of a penalty. Any decision
adverse to the athlete may be appealed to the CAS for a
final determination.
Notwithstanding the rights of an athlete to appeal the
IOC's determination, the USOC grievance procedures
continue to be effective. Thus, after the IOC determines
that a doping violation has occurred, an athlete could
presumably invoke the American Arbitration Association
arbitration process to prevent his or her removal from
the U.S. Olympic team. 55 As a result, it is again unclear
whether the athlete is required to adhere to those proce-
dures set forth by the IOC or whether he or she can pur-
sue an appeal before the AAA.
What Does This Mean for Amanda ?
A great deal. Prior to the start of the U.S. Olympic
Team Trials for track & field, Amanda can expect to be
drug tested by every one of the organizations mentioned
above, both in and outside of competition. For those com-
petitions that take place in the United States, drug test-
ing will be conducted by the USOC. 56 If Amanda travels
to Australia, she should expect to be drug tested by the
ASDA.5 7 Finally, Amanda should expect to be drug test-
ed outside of competition in both the United States and Canada
by the USOC, the IAAF, the ASDA, and/or the WADA.
If any of the samples taken prior to or during the U.S.
Olympic Team Trials for track & field reveals the pres-
ence of a prohibited substance, Amanda can expect to be
notified by USATF of the positive finding. At such time,
Amanda would be entitled to the opportunities afforded
by USATF Regulation 10. If USATF determines that a
doping violation has occurred, Amanda would have
recourse through Article IX of the USOC Constitution
and Chapter IX of the USOC By-Laws to re-examine her
eligibility status for the U.S. Olympic trials and the
Olympic Games.
Upon completion of the U.S. Olympic trials, Amanda
still can expect to be drug tested by the USOC, the IAAF,
the ASDA, or the WADA. However, whether USATF will
be responsible for conducting disciplinary proceedings
will depend on whether Amanda has been nominated to
the U.S. Olympic team.
If Amanda is not nominated to the U.S. Olympic team
for track & field, and a sample taken after the Olympic
trials reveals the presence of a prohibited substance,
Amanda can expect disciplinary proceedings to be con-
ducted by USATF, pursuant to USATF Regulation 10.
However, if Amanda is nominated to the U.S. Olympic
team, and a sample taken before or after the Olympic tri-
als reveals the presence of a prohibited substance, it is
unclear which organization - USATF or the USOC -
would implement disciplinary proceedings. What is
clear, however, is that Amanda would have recourse
through Article IX of the USOC Constitution and
Chapter IX of the USOC By-Laws, if either the USOC or
USATF first denied her the opportunity to compete in the
Olympic Games.
Conclusion
This Article only begins to touch on the many legal
issues associated with drug testing. Ultimately, it will be
up to you, the attorney, to navigate successfully the
impossibly complicated body of rules and regulations
associated with each organizations' drug testing pro-
gram, in order to adequately represent your client.
Understanding the many organizations within the
Olympic Movement that are involved with drug testing,
as well as the different responsibilities of these organiza-
tions, will be a very challenging task. However, one thing
should be apparent - drug testing is certain to occur,
whether it be during a competition or outside a competi-
tion. Thus, understanding the differences between the
United States Olympic Committee, the International
Federation, the World Anti-doping Agency, and any other
organizations that may have the authority to drug test
an athlete, may be the most important thing that an ath-
lete can do to prepare for the 2000 Olympic Games. *
1 The term of art for drug testing within the Olympic Movement is
"doping control." These terms are interchanged throughout this
Article. Drug testing is the process that has been developed over time
to ensure that an athlete has not used a performance-enhancing sub-
stance or technique. It includes taking a urine sample from an ath-
lete and analyzing that sample for both prohibited substances and
techniques. While urine is the body fluid that is currently analyzed,
the International Olympic Committee has indicated that blood may
also be analyzed during the 2000 Sydney Games.
2 See id.
3 The term Olympic Movement "stems from modern Olympism." It
"encompasses organizations, athletes, and other persons who agree to
be bound by the Olympic Charter." Criterion for belonging to the
Olympic Movement is recognition by the International Olympic
Committee. See International Olympic Committee Charter §§ 4-5, The
Olympic Charter (visited April 14, 2000) <http://www.olympic.org/
ioc/e/facts/charter/charter intro e.html> [hereinafter IOC Charter].
4 See id.
5 See generally, Medical Commission (visited April 14, 2000)
<http://iisl.us. olympic.org/ioc/e/org/medcom/medcom%/5Fintro
%5Fe.html> [hereinafter IOC Medical Commission].
6 See generally, IAAF Rules and Regulations (visited April 14, 2000)
<http://archive.www.worldsport.com/worldsport/sports/athletics/rules/r
ules.html> [hereinafter IAAF Rules].
7 See generallv, IAAF Division III (visited April 14, 2000)
<http://archive.www.worldsport.com/worldsport/sports/athletics/
rules/32.html>.
8 Ted Stevens Olympic and Amateur Sports Act, 36 U.S.C. § 2205
(1998).
9 USOC Drug Control Administration (visited April 14, 2000)
<http://www.olympic-usa.org/inside/drugadmin.html> [hereinafter
USOC NADP].
10 On file with Authors.
11 USOC Constitution (visited April 14, 2000) <http://www.usoc.
org/c&b/constitution.html>.
12 USOC By-Laws (visited April 14, 2000) <http://www.usoc.
org/c&blbylaws.html>.
13 On file with the United States Olympic Committee. See generallv,
USOC Code of Ethics (visited April 19, 2000) <http://www.usoc.org/
c&b/ethics.html>.
14 On file with the United States Olympic Committee. See generallv,
USOC Constitution, supra note 11, at art. VIII.
15 On file with the United States Olympic Committee.
16 Id.
17 USA Track & Field (USATF) is the recognized national governing
body (NGB) for track & field, long distance running, cross country,
and race-walking in the United States. As the NGB, USATF is
responsible for coordinating all aspects of the sport in the United
States, including nominating members to the U.S. Olympic team in
the sport of track & field.
18 USA TRACK & FIELD, GOVERNANCE HANDBOOK (2000) [hereinafter
USATF Handbook].
19 One major difference between in-competition and out-of-competi-
tion drug testing for track & field is the type of prohibited substance
that may be tested for by the laboratory. In-competition drug tests
are screened for stimulants, anabolic agents, amphetamines, peptides,
glycoprotein, glucocorticoid hormones, and prohibited techniques.
Out-of-competition drug tests are screened for anabolic agents, pep-
tides, glycoprotein, glucocorticoid hormones, and prohibited tech-
niques. See IAAF Procedural Guidelines For Doping Control, List of
Prohibited Substances, supra note 7, at Schedule I, Part III.
20 Athletes are a given "reasonable" time in which to complete the
activity in which they are currently engaged. See id. supra note 7, at §
3.9; USOC NAPD, supra note 9, at § 9.
21 Failure of an athlete to submit to drug testing is considered to be a
doping violation, and he or she would be subject to the same penalties
associated with failing a drug test. For more information, see IOC
Medical Code; supra note 5; IAAF Rule 56, supra note 6; USOC
NADP, supra note 9; USATF Regulation 10, supra note 18.
22 "Authority," as used throughout this Article, is meant to include
the ability to conduct drug testing.
23 For example, a U.S. athlete who is ranked number two in the
world, in a particular event, has a much greater chance of being drug
tested by all four organizations than a U.S. athlete who is ranked
number ten in the United States.
24 The United States Olympic Committee is the United States' repre-
sentative - the National Olympic Committee (NOC) - in the
International Olympic Committee. As such, the USOC is responsible
for coordinating the activity of all American-based Olympic and Pan
American sport organizations in the United States.
25 Each sport within the Olympic Movement has a national federa-
tion, which is responsible for coordinating the activity for that particu-
lar sport in its country. In the United States these federations are
known as "national governing bodies" (NGB). USA Track & Field is
the NGB for track & field, long distance running, cross country, and
race-walking in the United States. For more information on recogni-
tion of NGBs in the United States, see Ted Stevens Olympic and
Amateur Sports Act, supra note 8, at §2205.
26 See USOC NADP, supra note 9, at § 9.1(b).
27 The USOC implements a No-Advance-Notice (NAN) out-of-competi-
tion drug-testing program. This means that athletes are given no
notice that the out-of-competition drug test is going to occur. See id. at
Attachment 6.
28 Each national federation within the Olympic Movement belongs to
an international federation - the worldwide governing body for that
particular sport. The international federation is responsible for all
technical aspects of the sport outside the Olympic Games.
29 It is a condition of membership in the IAAF that each NGB abide
by the IAAF Rules and Regulations, which provide for both in-compe-
tition and out-of-competition drug testing. See IAAF Rules, supra note
6, at Rules 2, 55-61.
30 See id. at Rule 58.1.
31 See id. at Rule 57.1(iii).
32 An example of an LAAF-sanctioned event held in the United States
is the Prefontaine Classic, which is held every spring in Portland,
Oregon, in honor of the late Steve Prefontaine. This competition is an
IAAF Grand Prix event.
33 A similar bilateral agreement, between CCES and the USOC, is
expected to be signed in the next few months.
34 The ability to drug test another federation's athlete has a "reason-
ableness" standard built into the provisions. A party to the agreement
cannot drug test an athlete more than twice during the same visit
without the consent of the other party. Thus, a federation cannot
abuse its authority to drug test another federation's athletes.
35 Thus, if your client were to be drug tested in Australia and the
drug test revealed the presence of a prohibited substance, your client
would have the ability to have a hearing before USATF, the athlete's
home federation. For more information, see USOC/ASDA Bilateral
Agreement, supra note 15, at § IV, Provision 9.
36 It should be noted that within the sport of track & field, of the 200
members of the IAAF, only eight have drug-testing programs.
37 See USOC NADP, supra note 9, at § 9.1.
38 See id. at § 6.20; IAAF Rule 59.3, supra note 6; USOC/ASDA
Bilateral Agreement, supra note 15, at § 4, Provision 9.
39 USATF Handbook, supra note 18, at Regulation 10.
40 The collection of a drug test includes dividing the urine sample
into two containers, respectively known as the "A" sample and the "B"
sample. The "A" sample is always analyzed first. The "B" sample is
only analyzed in the event the "A" sample reveals the presence of a
prohibited substance.
41 The USOC has set forth a "due process" checklist with which NGBs
are required to comply. The list includes notice of the specific charges,
reasonable time between the receipt of notice of charges and the hear-
ing, the right to have the hearing conducted at a convenient time and
place, the right to be assisted in the presentation of one's case at the
hearing, the right to a hearing before a disinterested and impartial
body of fact finders, the right to call witnesses and present both writ-
ten and oral evidence, the right to cross-examine, the right to a record
of the hearing, the right to a written decision, and the right to written
notice of appeal procedures. See USOC Constitution, supra note 11,
at Article IV, § 4, (C)(6).
42 USATF was the first NGB in the United States to out-source its
disciplinary process. The USOC has recently indicated that it plans to
follow suit.
43 Protected competition includes Olympic Games, Pan American
Games, Paralympic Games, World Championships competition, or
other protected competition as defined by Article I, Section 2 (H) of
the USOC Constitution. See USOC Constitution, supra note 11, at
Article IX, § 1.
44 An NGB would first have to deny an athlete the ability to partici-
pate in a protected competition. Thus, an athlete first would have had
a hearing pursuant to USATF Guideline Regulation 10. See USATF
Handbook, supra note 18, at Regulation 10.
45 See USOC Constitution, supra note 11, at Article IX.
46 See id. at Article III, § 5.
47 See Grievance Procedures for Code of Conduct and Team Selection
- 2000 Olympic Games, supra note 14. These Grievance Procedures
specify that the American Arbitration Association (AAA) will handle
any dispute that the Secretary General is unable to resolve.
48 See USOC/ASDA Bilateral Agreement, supra note 15, at § IV,
Provision 9.
49 See Grievance Procedures for Code of Conduct and Team Selection
- 2000 Olympic Games, supra note 14.
50 An additional issue that arises, but is not discussed in this Article,
is whether one organization may pursue disciplinary action after
action has been taken by the first organization.
51 See IOC Olympic Charter, supra note 3, at § 5.
52 See IOC Medical Code, supra note 5, at Chapter VI, Article IV,
Chapter III, Article I. Athletes agree to use the Court of Arbitration
for Sport (CAS) to resolve all issues relating to disciplinary action that
may arise during the conduct of the Olympic Games.
53 See id.
54 See id. at Chapter III, Article I.
55 See Grievance Procedures for Code of Conduct and Team Selection
- 2000 Olympic Games, supra note 14.
56 The USOC conducts testing unless the competition falls into one of
the categories specified by the IAAF Rules. In such case, the IAAF
would be responsible for conducting drug testing.
5 7 See id.
